课题基金 / 基金详情

The investigation of regulatory mechanism on liver regeneration after massive hepatectomy

The investigation of regulatory mechanism on liver regeneration after massive hepatectomy
大量肝切除术后肝再生的调控机制研究
批准号:
17591408
负责人:
FUJII Masahiko
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
背景)肝切除术后肝功能衰竭是最重要的术后并发症之一。此外,在肝移植后发生肝功能衰竭,小尺寸移植物是一个重要因素。本研究旨在阐明大规模肝切除术后的调控机制和术后肝衰竭的控制方法。方法与结果)对肝脏缺血再灌注损伤(I/R损伤)的调节作用(1)卵泡抑素大鼠模型,未观察到转氨酶水平和存活率的改善。(2)氟伐他汀术前治疗(口服)氟伐他汀可降低I/R损伤后转氨酶水平。此外,我们通过实时PCR方法证实了I/R损伤后eNOS、几种细胞因子和NOX4的表达。我们利用DNA芯片分析了肝癌切除术后的基因表达,证实STAT3和HO-1的基因表达在手术后增强。FK506对大块肝切除术后肝脏再生的调节作用(1)FK506在大块肝切除术(90%)模型中,FK506在术后72hr促进肝脏再生。大鼠肝大部切除(90%)模型血清FK506水平高于70%肝大部切除模型。(2)日本中草药:术前治疗(口服)有加速胆道排泄的作用,可提高术后生存率,降低转氨酶水平。此外,In-Chin-co-to还能加速大面积肝切除术后的肝脏再生。免疫组化染色显示PCNA和HO-1表达显著升高,SMA表达显著降低。(3)氟伐他汀术前治疗(口服)氟伐他汀对血管性他汀等I/R损伤有保护作用,可促进肝再生,降低肝切除术后总胆红素水平。摘要)本研究采用分子生物学方法,阐明了肝再生的调控机制,以及几种肝再生调节剂在大块肝切除术中的作用。然而,我们无法阐明激活素对肝脏再生的调节作用,因为我们在纯化激活素方面有困难。少
英文摘要
Background)Liver failure after massive hepatectomy is one of the most important postoperative complication. Furthermore, in outbreak of liver failure after liver tranplantation, small-for-size graft is an important factor. In this study, we conducted to clarify the regulatory mechanism after massive hepatecomy and the control method for postoperative liver failure.Method and Results)1. Regulation of ischemic reperfusion injury (I/R injury) of the liver(1) follistatinIn rat model, improvement of transaminase levels and survival rate were not observed.(2)fluvastatinPreoperative treatment (oral administration) of fluvastatin decreased transaminase levels after I/R injury. Furthermore, we confirmed expression of eNOS, several cytokines and NOX4 on realtime PCR method after I/R injury.2. Gene expression after massive hepatectomy (90%)We analyzed gene expression after massive hepatectomy using the DNA microarray, and confirmed that Gene expression of STAT3 and HO-1 was enhanced after operati … More on.3. Effect of modulation on liver regeneration after massive hepatectomy(1)FK506In massive hepaatectomy (90%) model, FK506 accelerated liver regeneration in 72hr after operation. Furthermore, serum level of FK506 in massive hepatectomy (90%) model was higher than that in 70% hepatectomy model.(2)In-Chin-co-to (Japanese herbal medicine)Preoperative treatment (oral administration) of In-Chin-co-to which have effect of acceleration for biliary excretion improved postoperative survival and decreased transaminase levels. Furthermore, In-Chin-co-to accelerated liver regeneration after massive hepatectomy. In immunohisitochemical staining, expression of PCNA and HO-1 was significantly higher and a SMA was significantly lower.(3) fluvastatinPreoperative treatment (oral administration) of fluvastatin which have protection effect for I/R injury such as vascular statin accelerated liver regeneration and decreased total-billilubin level afar massive hepatectomy. In immunohisitochemical staining, expression of a SMA was suppressedSummary)In this study, we clarified the regulatory mechanism of liver regeneration and effect of several modulators for liver regeneration on massive hepatectomy using molecular biological method. However, we were not able to elucidate the regulation of liver regeneration using activin, because we had difficulty with the purification of activin. Less
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
生体肝移植における過小グラフトの病態生理を治療戦略
活体肝移植中移植不足病理生理学的治疗策略
DOI: --
发表时间: 2006
期刊: 四国医学会雑誌 62巻1,2号
影响因子: --
作者: [Young J, Barker MA, Simms LA, Walsh MD, Biden KG, Buchanan D, Buttenshaw R, Whitehall VL, Amold S, Jackson L, Kambara T, Spring KJ, Jenkins MA, Walker GJ, Hopper JL, Leggett BA, Jass JR, 島田 光生]
通讯作者: 島田 光生
DOI: --
发表时间: 2006
期刊: Hepato-Gastroenterology 52
影响因子: --
作者: [Morine Y, Shimada M, Soejima Y, Fujii M, Imura S, Ikemoto T., Morine Y]
通讯作者: Morine Y
特集/生体肝移植における門脈・肝静脈再建 II.門脈再建早期・晩期門脈血栓症
专题/活体肝移植中的门静脉和肝静脉重建II.早期和晚期门静脉血栓的门静脉重建。
DOI: --
发表时间: 2006
期刊: 外科 68巻3号
影响因子: --
作者: [Takachi K, Doki Y, Ishikawa O, Miyashiro I, Sasaki Y, Ohigashi H, Murata K, Nakajima H, Hosoda H, Kangawa K, Sasakuma F, Imaoka S, Y.Morine, 森根 裕二]
通讯作者: 森根 裕二
Clincopathological features of uncontrorable recurrent hepatocellular carcinoma after non-surgical treatment
非手术治疗后无法控制的复发性肝细胞癌的临床病理特征
DOI: --
发表时间: 2006
期刊: Hepato-Gastroenterology Vol53, Supl.
影响因子: --
作者: [Young J, Barker MA, Simms LA, Walsh MD, Biden KG, Buchanan D, Buttenshaw R, Whitehall VL, Amold S, Jackson L, Kambara T, Spring KJ, Jenkins MA, Walker GJ, Hopper JL, Leggett BA, Jass JR, 島田 光生, Y.Morine, 森根 裕二, M.Kanamoto]
通讯作者: M.Kanamoto
19
    海外基金